Drug Profile
Streptokinase biosimilar - Biocon
Alternative Names: Myokinase; Recombinant streptokinase - BioconLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Biocon
- Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasmin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Deep vein thrombosis; Myocardial infarction; Pulmonary embolism
Most Recent Events
- 30 Apr 2008 Launched for Deep vein thrombosis in India (IV) before April 2008
- 30 Apr 2008 Launched for Myocardial infarction in India (IV) before April 2008
- 30 Apr 2008 Launched for Pulmonary embolism in India (IV) before April 2008